DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 6BUDESONIDE
02 1DEXILANT
03 1ENTOCORT EC
04 1ESOMEPRAZOLE MAGNESIUM
05 1ESOMEPRAZOLE STRONTIUM
06 1FENOFIBRIC ACID
07 1NEXIUM 24HR
08 1ORTIKOS
01 121324
02 122287
03 190379
04 1200920
05 1202342
06 1204655
07 1206134
08 1206200
09 1206623
10 1206724
11 1207367
12 1209339
13 1211929
01 11No
02 2Yes
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 206623
Country : US
Patented : No
Drug : FENOFIBRIC ACID
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 200920
Country : US
Patented : No
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 206200
Country : US
Patented : No
Drug : NEXIUM 24HR
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 204655
Country : US
Patented : No
Drug : ESOMEPRAZOLE MAGNESIUM
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 209339
Country : US
Patented : No
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 90379
Country : US
Patented : No
Drug : ESOMEPRAZOLE STRONTIUM
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 202342
Country : US
Patented : No
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 207367
Country : US
Patented : No
Drug : DEXILANT
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 22287
Country : US
Patented : Yes
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 206134
Country : US
Patented : No
